Latest filing published 14 Sept 2026 for DEXCOM INC, €260k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Jereme M. Sylvain in Dexcom Inc, where the filings describe the role as finance chief. The record holds 33 filings, for trades running from 24 May 2021 to 10 September 2026.
No open-market purchase appears, only 19 sales worth €5.8M. Besides market trades, the filings include 12 share grants. Since January 2026: no purchases and 1 sale on the market.
Most recently, on 14 September 2026, the filings show an open-market sale worth €260k in Dexcom Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 33 declarations